renal cell carcinoma

AVEO: Here's Looking At You, FDA
AVEO: Here's Looking At You, FDA
Seeking Alpha
Aveo Pharmaceuticals
tivozanib
renal cell carcinoma
Flag link:
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
Seeking Alpha
Aveo Pharmaceuticals
FDA
tivozanib
GSK
Onyx
Pfizer
renal cell carcinoma
Roche
Flag link:
Why We Expect The FDA To Approve Aveo's Tivozanib
Why We Expect The FDA To Approve Aveo's Tivozanib
Seeking Alpha
FDA
tivozanib
Aveo Pharmaceutical
renal cell carcinoma
Flag link:
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Delcath
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Chemosat
melanoma
metastatic melanoma
Flag link:
Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?
Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?
Seeking Alpha
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Flag link:
AVEO: Final Overall Survival Results From The TIVO­1 Study
AVEO: Final Overall Survival Results From The TIVO­1 Study
Seeking Alpha
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Flag link:
Pfizer's Torisel drug fails in a combination study
Pfizer's Torisel drug fails in a combination study
Yahoo/Reuters
Torisel
Pfizer
renal cell carcinoma
Flag link:
Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma
Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma
Yahoo/Business Wire
cabozantinib
renal cell carcinoma
Exelixis
Flag link:
FDA clears Pfizer drug for advanced kidney cancer
FDA clears Pfizer drug for advanced kidney cancer
Yahoo/AP
Pfizer
kidney cancer
renal cell carcinoma
Inlyta
Flag link:
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Bloomberg
Aveo Pharmaceutical
Astellas
renal cell carcinoma
tivozanib
Flag link:
Pfizer (PFE) Gets Favorable Outcome for Axitinib from FDA Committee
Pfizer (PFE) Gets Favorable Outcome for Axitinib from FDA Committee
StreetInsider.com
Axitinib
FDA
advisory panels
renal cell carcinoma
Pfizer
Flag link:
Pfizer's Axitinib Encourages
Pfizer's Axitinib Encourages
Yahoo/Zacks
Pfizer
Axitinib
renal cell carcinoma
Flag link:
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
Pharmabiz
GSK
Votrient
renal cell carcinoma
Flag link:
Miracle Cancer Drug Extends Life With $48,720 Cost (Update1)
Miracle Cancer Drug Extends Life With $48,720 Cost (Update1)
Businessweek
Sutent
Pfizer
gastrointestinal stromal tumors GIST
renal cell carcinoma
Flag link:
3SBIO Files for Approval on Three New Drugs
3SBIO Files for Approval on Three New Drugs
Seeking Alpha
3SBio
TPIAO
ITP
NuLeusin
renal cell carcinoma
EPIAO
Flag link:

Pages